Dr Agarwal's Health (AGARWALEYE) | Stock Overview & Key Data
Dr Agarwal's Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹568.00 on October 16, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dr Agarwal's Health
AGARWALEYE
|
138.86B Mid-cap | -2.72% | -2.40% | 3.65% | -11.79% | -12.18% | 17.19% | 9.38% | 9.38% | 9.38% | 9.38% | 9.38% |
|
Poly Medicure
POLYMED
|
151.00B Mid-cap | 9.26% | 0.80% | 20.33% | -19.36% | -13.29% | -31.00% | 33.68% | 70.32% | 703.44% | 4,602.06% | 4,602.06% |
|
Tarsons Products
TARSONS
|
11.01B Small-cap | -0.12% | -0.11% | 8.87% | -10.58% | -11.95% | -47.38% | -64.08% | -74.91% | -74.91% | -74.91% | -74.91% |
|
Laxmi Dental
LAXMIDENTL
|
10.40B Small-cap | 1.49% | 12.83% | 31.31% | -15.20% | -17.46% | -47.17% | -55.90% | -55.90% | -55.90% | -55.90% | -55.90% |
|
Prevest Denpro
PREVEST
|
5.42B Small-cap | -0.84% | -5.49% | -5.28% | -20.44% | -18.59% | -20.44% | -9.34% | 356.55% | 356.55% | 356.55% | 356.55% |
|
Shree Pacetronix
SHREEPAC
|
532.08M Small-cap | -0.39% | 4.04% | 31.20% | -46.19% | -22.04% | 73.55% | -37.38% | 1,403.82% | 743.43% | 289.00% | 1,913.14% |
Ownership & Short Interest
Calculate Your Dr Agarwal's Health Investment Returns
Long-Term Investment Performance Analysis
Dr Agarwal's Health stock price in Feb 2025 was ₹402.05, A ₹1,000.00 lump sum investment in Dr Agarwal's Health made 1 years ago would be worth approximately ₹1,092.65 today, representing a positive return of 9.27%. This translates to an annualized return (CAGR) of 6.73%.
1 Year 4 Months Investment Scenario (Feb 2025 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is AGARWALEYE's 52-week high and low?
- In the last 52 weeks, Dr Agarwal's Health reached a high of ₹568.00 (on N/A) and a low of ₹371.50 (on June 16, 2025).
- What is the market cap and P/E ratio for AGARWALEYE?
- Curious about Dr Agarwal's Health's size and valuation? Its market capitalization stands at 138.86B. When it comes to valuation, the P/E ratio (trailing twelve months) is 109.80, and the forward P/E (looking ahead) is 77.92.
- Does AGARWALEYE pay dividends? If so, what's the yield?
- As for dividends, Dr Agarwal's Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Dr Agarwal's Health's main competitors or similar companies to consider before investing?
When looking at Dr Agarwal's Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED151.00B Healthcare Medical Instruments & Supplies -31.00% 33.68% Tarsons Products
TARSONS11.01B Healthcare Medical Instruments & Supplies -47.38% -64.08% Laxmi Dental
LAXMIDENTL10.40B Healthcare Medical Instruments & Supplies -47.17% -55.90% Prevest Denpro
PREVEST5.42B Healthcare Medical Instruments & Supplies -20.44% -9.34% Shree Pacetronix
SHREEPAC532.08M Healthcare Medical Instruments & Supplies 73.55% -37.38% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dr Agarwal's Health Care Ltd? (e.g., ROE, Debt/Equity)
- To get a sense of Dr Agarwal's Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.33%, the Debt to Equity ratio from the most recent quarter is 48.68, and its Gross Profit Margin stands at 62.87%.
- What is the recent revenue and earnings growth for AGARWALEYE?
- Looking at Dr Agarwal's Health's growth, its revenue over the trailing twelve months (TTM) was INR20B. Compared to the same quarter last year (YoY), quarterly revenue grew by 23.00%, and quarterly earnings saw a YoY growth of 51.00%.
- How much of AGARWALEYE stock is held by insiders and institutions?
- Wondering who owns Dr Agarwal's Health stock? Company insiders (like executives and directors) hold about 75.49% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 16.46%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.